The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study

Detalhes bibliográficos
Autor(a) principal: Cardoso, M
Data de Publicação: 2019
Outros Autores: Alexandrino, G, Carvalho E Branco J2, Anapaz V2, Carvalho R2, Horta D2, Martins A2., Branco, J, Anapaz, V, Carvalho, R, Horta, D, Martins, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/2374
Resumo: Acute-on-chronic liver failure (ACLF) is a dynamic syndrome that should be assessed repeatedly. An algorithm for risk stratification in decompensated cirrhosis was recently proposed by the EASL-CLIF (European Association for the Study of the Liver-Chronic Liver Failure) Consortium. AIM: To validate the EASL-CLIF Consortium scores in patients with and without ACLF. MATERIALS AND METHODS: Retrospective single-center cohort study including patients admitted for acute decompensation of cirrhosis between January 2014 and December 2015, and followed-up until December 2016. We separated patients with and without ACLF and compared the various EASL-CLIF Consortium scores to Child-Pugh and MELD for predicting 28-day (M28), 90-day and 12-month mortality. These scores were recalculated at different time points over 28 days. RESULTS: 106 patients were included (age 60.3±10.7 years; 87.7% male), 35.8% of whom met ACLF criteria on admission (50%) or during hospitalization. A CLIF-C AD Score ≥60 on admission was associated with a higher risk of developing ACLF. The onset of ACLF during hospitalization portended a poor prognosis. The prognostic performance of the CLIF-C ACLF Score (AUROC for M28: 0.856±0.071) was globally comparable to that of Child-Pugh and MELD. Overall, ACLF resolved in 54.1% patients, resulting in increased survival. Almost 40% of the patients reached their final ACLF grade after ≥8 days, with 13.9% of ACLF patients experiencing resolution by then. DISCUSSION: We confirmed the accuracy and clinical value of the several proposed scores in our population. Prognosis was better defined by the early clinical course than by the initial evaluation, emphasizing the importance of repeated assessments.
id RCAP_d2273ebbb163a291e9f39148922d4674
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/2374
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center studyAcute-on-chronic liver failureLiver cirrhosisPortugalAcute-on-chronic liver failure (ACLF) is a dynamic syndrome that should be assessed repeatedly. An algorithm for risk stratification in decompensated cirrhosis was recently proposed by the EASL-CLIF (European Association for the Study of the Liver-Chronic Liver Failure) Consortium. AIM: To validate the EASL-CLIF Consortium scores in patients with and without ACLF. MATERIALS AND METHODS: Retrospective single-center cohort study including patients admitted for acute decompensation of cirrhosis between January 2014 and December 2015, and followed-up until December 2016. We separated patients with and without ACLF and compared the various EASL-CLIF Consortium scores to Child-Pugh and MELD for predicting 28-day (M28), 90-day and 12-month mortality. These scores were recalculated at different time points over 28 days. RESULTS: 106 patients were included (age 60.3±10.7 years; 87.7% male), 35.8% of whom met ACLF criteria on admission (50%) or during hospitalization. A CLIF-C AD Score ≥60 on admission was associated with a higher risk of developing ACLF. The onset of ACLF during hospitalization portended a poor prognosis. The prognostic performance of the CLIF-C ACLF Score (AUROC for M28: 0.856±0.071) was globally comparable to that of Child-Pugh and MELD. Overall, ACLF resolved in 54.1% patients, resulting in increased survival. Almost 40% of the patients reached their final ACLF grade after ≥8 days, with 13.9% of ACLF patients experiencing resolution by then. DISCUSSION: We confirmed the accuracy and clinical value of the several proposed scores in our population. Prognosis was better defined by the early clinical course than by the initial evaluation, emphasizing the importance of repeated assessments.Elsevier EspañaRepositório do Hospital Prof. Doutor Fernando FonsecaCardoso, MAlexandrino, GCarvalho E Branco J2, Anapaz V2, Carvalho R2, Horta D2, Martins A2.Branco, JAnapaz, VCarvalho, RHorta, DMartins, A2019-12-23T11:21:09Z2019-01-01T00:00:00Z2019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/2374engGastroenterol Hepatol. 2019 May;42(5):296-30310.1016/j.gastrohep.2018.11.007metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:53:03Zoai:repositorio.hff.min-saude.pt:10400.10/2374Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:53:18.973801Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
title The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
spellingShingle The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
Cardoso, M
Acute-on-chronic liver failure
Liver cirrhosis
Portugal
title_short The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
title_full The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
title_fullStr The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
title_full_unstemmed The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
title_sort The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study
author Cardoso, M
author_facet Cardoso, M
Alexandrino, G
Carvalho E Branco J2, Anapaz V2, Carvalho R2, Horta D2, Martins A2.
Branco, J
Anapaz, V
Carvalho, R
Horta, D
Martins, A
author_role author
author2 Alexandrino, G
Carvalho E Branco J2, Anapaz V2, Carvalho R2, Horta D2, Martins A2.
Branco, J
Anapaz, V
Carvalho, R
Horta, D
Martins, A
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Cardoso, M
Alexandrino, G
Carvalho E Branco J2, Anapaz V2, Carvalho R2, Horta D2, Martins A2.
Branco, J
Anapaz, V
Carvalho, R
Horta, D
Martins, A
dc.subject.por.fl_str_mv Acute-on-chronic liver failure
Liver cirrhosis
Portugal
topic Acute-on-chronic liver failure
Liver cirrhosis
Portugal
description Acute-on-chronic liver failure (ACLF) is a dynamic syndrome that should be assessed repeatedly. An algorithm for risk stratification in decompensated cirrhosis was recently proposed by the EASL-CLIF (European Association for the Study of the Liver-Chronic Liver Failure) Consortium. AIM: To validate the EASL-CLIF Consortium scores in patients with and without ACLF. MATERIALS AND METHODS: Retrospective single-center cohort study including patients admitted for acute decompensation of cirrhosis between January 2014 and December 2015, and followed-up until December 2016. We separated patients with and without ACLF and compared the various EASL-CLIF Consortium scores to Child-Pugh and MELD for predicting 28-day (M28), 90-day and 12-month mortality. These scores were recalculated at different time points over 28 days. RESULTS: 106 patients were included (age 60.3±10.7 years; 87.7% male), 35.8% of whom met ACLF criteria on admission (50%) or during hospitalization. A CLIF-C AD Score ≥60 on admission was associated with a higher risk of developing ACLF. The onset of ACLF during hospitalization portended a poor prognosis. The prognostic performance of the CLIF-C ACLF Score (AUROC for M28: 0.856±0.071) was globally comparable to that of Child-Pugh and MELD. Overall, ACLF resolved in 54.1% patients, resulting in increased survival. Almost 40% of the patients reached their final ACLF grade after ≥8 days, with 13.9% of ACLF patients experiencing resolution by then. DISCUSSION: We confirmed the accuracy and clinical value of the several proposed scores in our population. Prognosis was better defined by the early clinical course than by the initial evaluation, emphasizing the importance of repeated assessments.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-23T11:21:09Z
2019-01-01T00:00:00Z
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/2374
url http://hdl.handle.net/10400.10/2374
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Gastroenterol Hepatol. 2019 May;42(5):296-303
10.1016/j.gastrohep.2018.11.007
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier España
publisher.none.fl_str_mv Elsevier España
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130400520404992